Dekkers

Mr. Dekkers: That's been going on for quite a while.

Bayer: Pressure on Prices Has Bad Side Effects Geoffrey Rogow 2012

Mr. Dekkers: The issue with these large acquisitions is that you pay a large premium up front and it is hard to earn back that premium for your investors in general.

Bayer: Pressure on Prices Has Bad Side Effects Geoffrey Rogow 2012

Andrew Quilty or The Wall Street Journal Bayer's Marijn Dekkers, shown in Sydney last month, says drug companies struggle with getting society to put value on what they do.

Bayer: Pressure on Prices Has Bad Side Effects Geoffrey Rogow 2012

Mr. Dekkers: In the pharmaceutical industry we have about 12 years to have patent protection on a drug and then it expires.

Bayer: Pressure on Prices Has Bad Side Effects Geoffrey Rogow 2012

Mr. Dekkers: On the health-care side, we have the products and are training expert salespeople to sell them.

Bayer: Pressure on Prices Has Bad Side Effects Geoffrey Rogow 2012

Mr. Dekkers: I understand governments are under pressure because of the debt situation and as a result of debt, governments put pressure on pharmaceutical companies to cut prices of medicine.

Bayer: Pressure on Prices Has Bad Side Effects Geoffrey Rogow 2012

"We'll have to deal intensively with the current challenges — in particular at HealthCare and CropScience," said Chief Executive Marijn Dekkers.

Chemicals Recovery Aids Bayer Natascha Divac 2010

"We're experiencing a slight weakening in demand," said Bayer Chief Executive Marijn Dekkers , pointing in particular to the construction industry in China which is having a negative impact on Bayer's polyurethane business.

Bayer Earnings Beat Views Natascha Divac 2011

Chief Executive Marijn Dekkers said he is very confident with the drug pipeline, adding he expects the pharmaceutical segment to grow "more than proportionally" over coming years.

Bayer Delivers a Mixed Bag Natascha Divac 2011

The 54-year-old Mr. Dekkers recently spoke with The Wall Street Journal en route to the semifinals of the Australian Open tennis championships in Melbourne about drug makers' need for recognition, expansion in China and his strategy for the Euro zone.

Bayer: Pressure on Prices Has Bad Side Effects Geoffrey Rogow 2012